AbbVie
ABBV
#30
Rank
A$615.08 B
Marketcap
A$348.07
Share price
0.89%
Change (1 day)
15.71%
Change (1 year)

The biotechnology and pharmaceutical company Abbvie, spelled AbbVie, was founded in 2013 as a spin-off from Abbott Laboratories and is traded on the NYSE stock exchange in the S&P 100 index under the symbol โ€œABBVโ€.

Earnings for AbbVie (ABBV)

Earnings in 2026 (TTM): A$8.92 Billion

According to AbbVie's latest financial reports the company's current earnings are A$62.81 Billion. In 2025 the company made an earning of A$9.33 Billion, an increase over its 2024 earnings that were of A$5.25 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for AbbVie from 2011 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) A$8.92 B-4.35%
2025 A$9.33 B77.53%
2024 A$5.25 B-40.54%
2023 A$8.84 B-53.62%
2022 A$19.06 B3.76%
2021 A$18.37 B282.25%
2020 A$4.80 B-59.67%
2019 A$11.92 B62.13%
2018 A$7.35 B-32.74%
2017 A$10.93 B-1.99%
2016 A$11.15 B18.65%
2015 A$9.40 B180.5%
2014 A$3.35 B-55.57%
2013 A$7.54 B-6.86%
2012 A$8.09 B56.05%
2011 A$5.18 B

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
A$14.98 B 77.26%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
A$44.03 B 420.92%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
A$12.85 B 52.08%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
A$2.29 B-72.84%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
A$15.17 B 79.55%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
A$13.57 B 60.62%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
A$20.74 B 145.42%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
A$14.16 B 67.55%๐Ÿ‡ฌ๐Ÿ‡ง UK
Neurocrine Biosciences
NBIX
A$1.13 B-86.63%๐Ÿ‡บ๐Ÿ‡ธ USA